Alzbeta Pharmaceuticals Private Limited
About Alzbeta Pharmaceuticals Private Limited
Data last updated:
Alzbeta Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 27 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC311099. Its GSTIN is 07AAPCA1208E1Z1 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shiv Kumar Tiwari and Sharwan Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 43 Block – A Mange Ram Park Landmark Near Shukar Bazar Road, New Delhi, Delhi, India – 110086.
As per the financials filed for FY 2017, the company reported a revenue of ₹43,125. For the same year it recorded a net profit of ₹206 (net margin 0.5%) and EBITDA of ₹14,351 (EBITDA margin 33.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alzbeta Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 43 Block – A Mange Ram Park Landmark Near Shukar Bazar Road, New Delhi, Delhi, India – 110086
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Alzbeta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alzbeta Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Alzbeta Pharmaceuticals Private Limited, buy the company report.
Financials of Alzbeta Pharmaceuticals Private Limited
FY 2025 filings availableAlzbeta Pharmaceuticals Private Limited reported revenue of ₹43,125 for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹43,125 |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹14,351 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹206 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | 33.3% |
| Net Profit Margin | 0.5% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Alzbeta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alzbeta Pharmaceuticals Private Limited
Alzbeta Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Kumar Tiwari | Director | 27 Jan 2017 | 9 Years 8 Months | Current |
| Sharwan Kumar | Director | 27 Jan 2017 | 9 Years 8 Months | Current |
Auditor
Alzbeta Pharmaceuticals Private Limited is audited by K B D S & CO. CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K B D S & CO. CHARTERED ACCOUNTANTS | FY 2017 | 323288E |
Shareholding
The shareholding of Alzbeta Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Alzbeta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alzbeta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alzbeta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alzbeta Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAPCA1208E1Z1 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alzbeta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alzbeta Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Sharwan Kumar was appointed as Director on 27 Jan 2017.
Frequently asked questions
Alzbeta Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in retailers, within the trading industry. It was incorporated on 27 January 2017 (9+ years old) and is registered under CIN U51909DL2017PTC311099.
Alzbeta Pharmaceuticals has 2 current directors:
- Shiv Kumar Tiwari - Director
- Sharwan Kumar - Director
The latest financial statements of Alzbeta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Alzbeta Pharmaceuticals is 07AAPCA1208E1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Alzbeta Pharmaceuticals is U51909DL2017PTC311099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alzbeta Pharmaceuticals was incorporated on 27 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Sharwan Kumar was appointed as Director on 27 Jan 2017. Shiv Kumar Tiwari was appointed as Director on 27 Jan 2017.
The registered office of Alzbeta Pharmaceuticals is at House No. 43 Block – A Mange Ram Park Landmark Near Shukar Bazar Road, New Delhi, Delhi, India – 110086.
Alzbeta Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Alzbeta Pharmaceuticals is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.